0001179110-16-026304.txt : 20160609
0001179110-16-026304.hdr.sgml : 20160609
20160609162947
ACCESSION NUMBER: 0001179110-16-026304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160608
FILED AS OF DATE: 20160609
DATE AS OF CHANGE: 20160609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Thomas Andrew
CENTRAL INDEX KEY: 0001338185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 161706309
MAIL ADDRESS:
STREET 1: 65 WEST WATKINS MILL ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
edgar.xml
FORM 4 -
X0306
4
2016-06-08
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001338185
Davis Thomas Andrew
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
0
1
0
0
Executive VP & CMO
Incentive Stock Option
4.72
2016-06-08
4
A
0
157000
0
A
2017-06-08
2026-06-08
Common Stock
157000
157000
D
25% vest on June 8, 2017 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Avery W. Catlin, attorney in fact for Thomas A. Davis
2016-06-09